Entourage_logo (002).jpg
Entourage Health Reports Fiscal Year 2023 Financial Results and Posts $54 Million in Total Revenues
April 30, 2024 07:13 ET | Entourage Health Corp.
Gross profit before fair value changes reached $2.4 million, reflecting a 126% year-over-year increase.Company demonstrates financial gains with a 23% reduction in the cost of goods sold.SG&A...
Entourage_logo (002).jpg
Entourage Health Reports Second Quarter 2023 Financial Results
August 30, 2023 07:41 ET | Entourage Health Corp.
The Company achieved a total revenue of $13.3 million, driven by an 8% increase in adult-use revenue and a significant 45% increase in pre-roll revenue year-over-yearGross Profit Before Fair Value...
Entourage_logo (002).jpg
Entourage Health Launches Dime Bag® Branded Pre-Rolls and Introduces Syndicate: A Collective of Craft Cannabis 
August 24, 2023 08:36 ET | Entourage Health Corp.
Entourage addresses market demand for affordable premium cannabis with new brand, Dime Bag® The Company announces Syndicate, a collective of exclusive cultivars from micro-cultivators  TORONTO, Aug. ...
Entourage_logo (002).jpg
Entourage Health Announces International Sale of Bulk Cannabis to Australia
July 04, 2023 08:30 ET | Entourage Health Corp.
Company successfully executes international sale and fulfilment of 100kg order of Bulk Medical Cannabis with Lyphe AustraliaCompany also issues Deferred Share Units to Board of Directors as Quarterly...
Entourage_logo (002).jpg
Entourage Health to Host First Quarter 2023 Earnings Conference Call
May 15, 2023 07:30 ET | Entourage Health Corp.
Company financials to be filed after market on May 29, 2023, and operational outlook to be provided during call, including milestones achieved. Company announces issuance of 1,423,057 common shares...